MAS1L

gene
On this page

Also known as MAS-LMRGdJ994E9.2

Summary

MAS1L (MAS1 proto-oncogene like, G protein-coupled receptor, HGNC:13961) is a protein-coding gene on chromosome 6p22.1, encoding Mas-related G-protein coupled receptor MRG (P35410).

Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane.

Source: NCBI Gene 116511 — RefSeq curated summary.

At a glance

  • GWAS associations: 21
  • Clinical variants (ClinVar): 59 total
  • Druggable target: yes
  • MANE Select transcript: NM_052967

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13961
Approved symbolMAS1L
NameMAS1 proto-oncogene like, G protein-coupled receptor
Location6p22.1
Locus typegene with protein product
StatusApproved
AliasesMAS-L, MRG, dJ994E9.2
Ensembl geneENSG00000204687
Ensembl biotypeprotein_coding
OMIM607235
Entrez116511

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000377127

RefSeq mRNA: 1 — MANE Select: NM_052967 NM_052967

CCDS: CCDS4661

Canonical transcript exons

ENST00000377127 — 1 exons

ExonStartEnd
ENSE000017585962948669729487956

Expression profiles

Bgee: expression breadth broad, 58 present calls, max score 57.06.

Top tissues by expression

121 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
smooth muscle tissueUBERON:000113557.06gold quality
gall bladderUBERON:000211056.64gold quality
rectumUBERON:000105252.75gold quality
lower esophagus muscularis layerUBERON:003583351.48gold quality
lower esophagusUBERON:001347351.38gold quality
mucosa of transverse colonUBERON:000499151.26gold quality
lower esophagus mucosaUBERON:003583451.18gold quality
esophagogastric junction muscularis propriaUBERON:003584150.60gold quality
subcutaneous adipose tissueUBERON:000219049.53gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099149.34silver quality
duodenumUBERON:000211448.07gold quality
right coronary arteryUBERON:000162547.45gold quality
skin of abdomenUBERON:000141646.43gold quality
zone of skinUBERON:000001446.06gold quality
muscle tissueUBERON:000238545.96gold quality
colonic epitheliumUBERON:000039745.87gold quality
skin of legUBERON:000151145.82gold quality
esophagusUBERON:000104345.59gold quality
adipose tissueUBERON:000101345.38gold quality
minor salivary glandUBERON:000183043.19gold quality
saliva-secreting glandUBERON:000104442.97gold quality
urinary bladderUBERON:000125542.71gold quality
ectocervixUBERON:001224942.67gold quality
mucosa of stomachUBERON:000119941.95silver quality
uterine cervixUBERON:000000241.34gold quality
small intestineUBERON:000210840.80gold quality
fundus of stomachUBERON:000116040.61gold quality
omental fat padUBERON:001041440.45gold quality
esophagus mucosaUBERON:000246940.23gold quality
tibial nerveUBERON:000132339.77gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • Mas, MrgD, and MRG mediated Ang IV-stimulated AA release that was highest for Mas. While Ang III activated Mas and MrgX2, Ang II stimulated AA release via Mas and MRG. (PMID:18636314)

Cross-species orthologs

0 orthologs

Paralogs (10): MAS1 (ENSG00000130368), MRGPRX1 (ENSG00000170255), MRGPRF (ENSG00000172935), MRGPRD (ENSG00000172938), GPR152 (ENSG00000175514), MRGPRX4 (ENSG00000179817), MRGPRX3 (ENSG00000179826), MRGPRG (ENSG00000182170), MRGPRX2 (ENSG00000183695), MRGPRE (ENSG00000184350)

Protein

Protein identifiers

Mas-related G-protein coupled receptor MRGP35410 (reviewed: P35410)

Alternative names: MAS1-like

All UniProt accessions (2): P35410, W8W3J1

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Cell membrane.

Similarity. Belongs to the G-protein coupled receptor 1 family. Mas subfamily.

RefSeq proteins (1): NP_443199* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000276GPCR_RhodpsnFamily
IPR017452GPCR_Rhodpsn_7TMDomain
IPR026234MRGPCRFAMILYFamily

UniProt features (21 total): topological domain 8, transmembrane region 7, glycosylation site 2, chain 1, region of interest 1, compositionally biased region 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P35410-F166.760.12

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 54, 57

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 13 (showing top): WTGAAAT_UNKNOWN, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, MAFG_TARGET_GENES, WP_GPCRS_CLASS_A_RHODOPSINLIKE, WP_MALE_INFERTILITY, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN, MODULE_337, chr6p22, GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP, CEBP_C

GO Biological Process (2): G protein-coupled receptor signaling pathway (GO:0007186), signal transduction (GO:0007165)

GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)

GO Cellular Component (4): nucleoplasm (GO:0005654), cytosol (GO:0005829), plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
G protein-coupled receptor activity1
signal transduction1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
nuclear lumen1
cytoplasm1
membrane1
cell periphery1

Protein interactions and networks

STRING

284 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MAS1LNPFFO15130822
MAS1LACEP12821811
MAS1LAGTR1P30556790
MAS1LACE2Q9BYF1790
MAS1LAGTP01019761
MAS1LRENP00797720
MAS1LTMPRSS2O15393479
MAS1LAGTR2P50052447
MAS1LKNG1P01042418
MAS1LBDKRB1P46663393
MAS1LADAM17P78536376
MAS1LSLC3A1Q07837372
MAS1LOR10C1Q96KK4371
MAS1LARGFXA6NJG6363
MAS1LRHOFQ9HBH0353

IntAct

1 interactions, top by confidence:

ABTypeScore
MAS1Lrl36a_rl36l_humanpsi-mi:“MI:0915”(physical association)0.400

BioGRID (1): RPL36AL (Affinity Capture-MS)

ESM2 similar proteins: P04201, P12526, P23749, P30554, P35410, P59534, P59535, Q3KNA1, Q3UG50, Q3UG61, Q4VHE7, Q645S5, Q645U4, Q645Y7, Q645Y8, Q645Y9, Q646A9, Q646B0, Q646C8, Q646D3, Q646F0, Q646F1, Q67ER9, Q67ES7, Q67ET0, Q67ET2, Q7TN38, Q7TN41, Q7TN44, Q7TN51, Q7TQA5, Q7TQA6, Q7TQB8, Q8CIP3, Q8R4G1, Q8TDS7, Q8VCJ6, Q91WW2, Q91WW3, Q91ZB8

Diamond homologs: B9VR26, O55197, O88680, P04201, P12526, P23749, P30554, P35410, Q16581, Q2LL16, Q3KNA1, Q3UG50, Q3UG61, Q4QXU0, Q4QXU2, Q4QXU3, Q4QXU4, Q4QXU5, Q4QXU6, Q4QXX9, Q5REI5, Q5U9D9, Q6L786, Q6TAC8, Q6XKD3, Q7TN38, Q7TN39, Q7TN40, Q7TN41, Q7TN44, Q7TN45, Q7TN49, Q7TN50, Q7TN51, Q86SM5, Q8CIP3, Q8NGA4, Q8R4G1, Q8TDS7, Q8VCJ6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

59 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance56
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

293 predictions. Top by Δscore:

VariantEffectΔscore
6:29486952:C:CTacceptor_gain0.8900
6:29487805:C:CCacceptor_gain0.8400
6:29486952:C:Tacceptor_gain0.8300
6:29487803:CA:Cacceptor_gain0.8200
6:29487802:CCA:Cacceptor_gain0.8000
6:29487803:CAC:Cacceptor_gain0.8000
6:29487931:CA:Cdonor_gain0.7800
6:29487932:A:ACdonor_gain0.7800
6:29487800:CACCA:Cacceptor_gain0.7000
6:29487928:CAACA:Cdonor_gain0.7000
6:29487713:T:Cdonor_gain0.6900
6:29486954:C:CTacceptor_gain0.6600
6:29486955:A:Tacceptor_gain0.6400
6:29486983:C:CCacceptor_gain0.6400
6:29487801:ACCAC:Aacceptor_loss0.6100
6:29487803:CACTG:Cacceptor_loss0.6100
6:29487804:ACTG:Aacceptor_loss0.6100
6:29487805:CTGT:Cacceptor_loss0.6100
6:29487806:T:Gacceptor_loss0.6100
6:29487807:G:Cacceptor_loss0.6100
6:29486987:T:TCacceptor_gain0.6000
6:29487430:T:TGacceptor_gain0.5900
6:29486978:CGCTG:Cacceptor_gain0.5800
6:29486980:CTG:Cacceptor_gain0.5800
6:29486948:TCCCC:Tacceptor_gain0.5700
6:29487913:G:Tdonor_gain0.5700
6:29487808:TGGAG:Tacceptor_loss0.5600
6:29487809:GGAGA:Gacceptor_loss0.5600
6:29487814:C:CTacceptor_loss0.5600
6:29486992:A:ACacceptor_gain0.5500

AlphaMissense

2475 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:29486979:G:CS308R0.951
6:29486979:G:TS308R0.951
6:29486981:T:GS308R0.951
6:29487399:G:CS168R0.942
6:29487399:G:TS168R0.942
6:29487401:T:GS168R0.942
6:29487084:G:CF273L0.938
6:29487084:G:TF273L0.938
6:29487086:A:GF273L0.938
6:29487174:A:CS243R0.931
6:29487174:A:TS243R0.931
6:29487176:T:GS243R0.931
6:29487533:A:GC124R0.915
6:29487296:A:GC203R0.911
6:29487372:G:CF177L0.911
6:29487372:G:TF177L0.911
6:29487374:A:GF177L0.911
6:29487438:G:CF155L0.907
6:29487438:G:TF155L0.907
6:29487440:A:GF155L0.907
6:29487185:A:GC240R0.905
6:29487311:A:GW198R0.902
6:29487311:A:TW198R0.902
6:29487321:G:CC194W0.901
6:29487622:C:TG94D0.901
6:29487623:C:GG94R0.886
6:29487432:A:CF157L0.885
6:29487432:A:TF157L0.885
6:29487434:A:GF157L0.885
6:29486977:G:TA309D0.884

dbSNP variants (sampled 300 via entrez): RS1000009425 (6:29488355 TCACTG>T), RS1001537013 (6:29489527 G>A,C), RS1001651577 (6:29489379 A>G), RS1002408193 (6:29486623 A>C), RS1004890390 (6:29489047 A>G), RS1005266319 (6:29489357 G>T), RS1008687129 (6:29488745 C>G), RS1009173038 (6:29489185 T>C), RS1009759126 (6:29488669 G>A,C), RS1012135798 (6:29489601 T>C), RS1012249887 (6:29486330 A>T), RS1012279024 (6:29488291 T>C), RS1012630423 (6:29486614 G>A), RS1012766229 (6:29488004 G>A,T), RS1017556350 (6:29488457 G>A)

Disease associations

OMIM: gene MIM:607235 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

21 associations (top):

StudyTraitp-value
GCST002884_1Cutaneous lupus erythematosus8.000000e-10
GCST004521_112Autism spectrum disorder or schizophrenia3.000000e-26
GCST004521_171Autism spectrum disorder or schizophrenia4.000000e-14
GCST004521_263Autism spectrum disorder or schizophrenia7.000000e-17
GCST004521_268Autism spectrum disorder or schizophrenia7.000000e-12
GCST004521_295Autism spectrum disorder or schizophrenia6.000000e-18
GCST004521_43Autism spectrum disorder or schizophrenia2.000000e-27
GCST004521_56Autism spectrum disorder or schizophrenia1.000000e-22
GCST004521_58Autism spectrum disorder or schizophrenia1.000000e-17
GCST004521_62Autism spectrum disorder or schizophrenia1.000000e-10
GCST005541_8Sarcoidosis (Lofgren’s syndrome vs non-Lofgren’s syndrome)1.000000e-20
GCST008745_56Estimated glomerular filtration rate in non-diabetics9.000000e-09
GCST010002_46Refractive error2.000000e-20
GCST010142_16Fish- and plant-related diet2.000000e-10
GCST010142_19Fish- and plant-related diet4.000000e-10
GCST010142_34Fish- and plant-related diet7.000000e-09
GCST010142_35Fish- and plant-related diet8.000000e-09
GCST010142_42Fish- and plant-related diet1.000000e-08
GCST010142_7Fish- and plant-related diet3.000000e-12
GCST010702_75Subcortical volume (MOSTest)3.000000e-11
GCST010703_272Brain morphology (MOSTest)7.000000e-16

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0008111diet measurement
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4523857 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Class A Orphans with emerging pharmacology

CTD chemical–gene interactions

5 total (human), top 5 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Sdecreases methylation1
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyreneincreases methylation1
Folic Aciddecreases expression1
Plant Extractsdecreases expression, affects cotreatment1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4883522BindingPRESTO-Tango GPCRome screening (MAS1L)Data for DCP probe UCSF924

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cutaneous lupus erythematosus, sarcoidosis